Search results for "Ophthalmology"

showing 10 items of 1738 documents

Determination of inmune response and inflammation mediators in tears: Changes in dry eye and glaucoma as compared to healthy controls

2017

Objective To determine the expression profile of immune response and inflammation (IRI) mediator molecules in tears from patients with dry eye (DE), and those suspected of having or have primary open-angle glaucoma (POAG) under treatment and compare them with healthy controls. Methods A prospective observational cohort study including 107 participants sub-divided into: healthy controls (CG; n = 30), patients with DE (DEG; n = 41) and patients suspected of having or have POAG and on hypotensive treatment (POAG-G; n = 36). Tear samples were collected by capillary to be processed using a multi-immunoassay system based on flow cytometry (Luminex R-200®), in order to determine the interleukins (…

0301 basic medicinemedicine.medical_specialtygenetic structuresGlaucomaAlpha (ethology)InflammationGastroenterologyFlow cytometry03 medical and health sciences0302 clinical medicineImmune systemInternal medicineMedicinemedicine.diagnostic_testbusiness.industryInterleukinGeneral Medicinemedicine.diseaseeye diseases030104 developmental biologyImmunology030221 ophthalmology & optometryTearsTumor necrosis factor alphasense organsmedicine.symptombusinessArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct

Imbalance Between Oxidative Stress and Growth Factors in Human High Myopia.

2020

Este artículo se encuentra disponible en la siguiente URL: https://www.frontiersin.org/articles/10.3389/fphys.2020.00463/full Myopia is one of the commonest eye pathologies that could affect 2.56 billion people by 2020. Today high myopia is a leading cause of blindness worldwide due to associated ocular illness. Nevertheless, the cellular bases for these diseases to develop are unclear in many areas. We conducted a prospective study of oxidative stress and growth factors in human myopic and non myopic eyes in an attempt to increase our understanding of the underlying physiopathological conditions to adequately early diagnose, prevent and treat the retina problem that derives from myopia. Aq…

0301 basic medicinemedicine.medical_specialtygenetic structuresNitratos.PhysiologyVEGF receptorsCrecimiento - Factores.Affect (psychology)medicine.disease_causelcsh:Physiology03 medical and health sciencesElisa kit0302 clinical medicineCataractsPhysiology (medical)OphthalmologyMedicineoxidative stresstotal nitratesNitrates.HGFProspective cohort studyhigh myopiaDioptreOriginal ResearchEstrés oxidativo.biologylcsh:QP1-981business.industryMiopía.High myopiaTACGrowth factors.medicine.diseaseVEGFeye diseasesOxidative stress.030104 developmental biology030221 ophthalmology & optometrybiology.proteinsense organsbusinessMyopia.Oxidative stressFrontiers in physiology
researchProduct

Update and guidance on management of myopia : European Society of Ophthalmology in cooperation with International Myopia Institute

2021

The prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, t…

0301 basic medicinemedicine.medical_specialtygenetic structuresmedicine.medical_treatmentatropinePsychological interventionReviewsorthokeratologylikinäköisyyspreventive medicineehkäisevä lääketiede03 medical and health sciences0302 clinical medicineOphthalmologynäkövammatEpidemiologyMyopiaPrevalenceMedicineHumansmyopiaPreventive healthcareBlindnessbusiness.industrypathologic myopiaPathological myopiaOrthokeratologyHigh myopiaTreatment optionsGeneral Medicinemedicine.diseasetime spent outdoorsmyopia reduction interventionsMyopia Degenerative/epidemiologyeye diseasesOphthalmology030104 developmental biologyMyopia Degenerativesilmätaudit030221 ophthalmology & optometryDisease Progressionsense organsbusinessOrthokeratologic Proceduresblindnesssokeus
researchProduct

Epiretinal Membrane Vitrectomy With and Without Intraoperative Intravitreal Dexamethasone Implant: A Systematic Review With Meta-Analysis

2021

Purpose: To evaluate the efficacy of vitrectomy combined with intravitreal dexamethasone implant vs. vitrectomy without the implant in patients with epiretinal membrane (ERM) by conducting a systematic review and meta-analysis.Methods: Studies that compared ERM vitrectomy with and without intraoperative dexamethasone implant with a follow-up ≥3 months were included. The primary outcome was mean best corrected visual acuity (BCVA) change between eyes undergoing ERM vitrectomy combined with dexamethasone implant (DEX group) and eyes undergoing ERM vitrectomy alone (control group) at 3 months. Secondary outcomes included mean BCVA change at 6 months and mean optical coherence tomography centra…

0301 basic medicinemedicine.medical_specialtygenetic structuresmedicine.medical_treatmentvitrectomyVitrectomy03 medical and health sciences0302 clinical medicineOphthalmologymedicinemacular puckerPharmacology (medical)In patientDexamethasone implantMacular thickeningDexamethasonePharmacologybusiness.industrylcsh:RM1-950epiretinal membrane (ERM)medicine.diseaseConfidence intervalmacular pucker surgerylcsh:Therapeutics. Pharmacology030104 developmental biologyDexamethasone implant; epiretinal membrane (ERM); macular pucker; macular pucker surgery; vitrectomyMeta-analysis030221 ophthalmology & optometrySystematic ReviewImplantEpiretinal membranebusinessmedicine.drug
researchProduct

How to Predict the Suitability for Corneal Donorship?

2021

Background: In Germany, more than one-third of donor corneas harvested are not suitable for transplantation. We evaluated the factors associated with the usability of donor corneas. Method: Data from 2032 consecutive donor corneas harvested at the Rhineland-Palatinate Eye Bank in Mainz, Germany, were retrospectively analyzed. Factors of interest were age, sex, lens status, cause of death, cardiopulmonary resuscitation (CPR), death-to-explantation-interval (DEI), and the influence of these factors on the proportion of discarded donor corneas. Factors associated with endothelial cell density (ECD) were analyzed in a linear regression mixed model. Results: Higher donor age, male gender, pseudo…

0301 basic medicinemedicine.medical_specialtygenetic structuressuitability for transplantationmedicine.medical_treatmentcorneal graftContext (language use)Articledeath-to-explantation interval03 medical and health sciences0302 clinical medicineOphthalmologyMedicineCardiopulmonary resuscitationcorneal bankingMale genderCause of deathbusiness.industryendothelial cell densityLens StatusREye bankGeneral Medicinedonor corneaeye diseasesTransplantationEndothelial cell density030104 developmental biology030221 ophthalmology & optometryMedicinesense organsbusinessJournal of Clinical Medicine
researchProduct

Hypervirulent Klebsiella pneumoniae Endogenous Endophthalmitis—A Global Emerging Disease

2021

The review aims to document the new emerging hypervirulent Klebsiella pneumoniae (Kp) endogenous endophthalmitis (EKE) in terms of incidence, microbiological characterization of the pathogenic agent, associated risk factors, management, and outcomes. Hypervirulent (hv) strains of KP (hvKp) induce invasive liver abscesses (LA) with specific clinical features. Up to 80–90% of cases have hepatic liver abscess as a primary focus of infection, followed by renal or lung hvKp infections. However, the incidence of EKE in patients with KPLA varied between 3.4% (19) and 12.6% (13), with a total of 95 cases of endophthalmitis in 1455 cases of KPLA (6.5%). Severe visual loss was encountered in 75% of c…

0301 basic medicinemedicine.medical_specialtymedicine.drug_classKlebsiella pneumoniaeScience030106 microbiologyCephalosporinDiseaseReviewGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesTherapeutic approach0302 clinical medicineEndophthalmitisAntibiotic resistanceInternal medicinemedicineEcology Evolution Behavior and Systematicshypervirulent Klebsiella pneumoniaepercutaneous drainagebiologybusiness.industryIncidence (epidemiology)intravitreal antibiotherapyQPaleontologymedicine.diseasebiology.organism_classificationhypervirulent <i>Klebsiella pneumoniae</i>endophthalmitisSpace and Planetary Science030221 ophthalmology & optometrybusinessinvasive liver abscess syndromeLiver abscessearly diagnosisLife
researchProduct

Symptomatic accommodative and binocular dysfunctions from the use of flat-panel displays

2018

AIM: To determine the presence of symptomatic accommodative and non-strabismic binocular dysfunctions (ANSBD) in a non-presbyopic population of video display unit (VDU) users with flat-panel displays. METHODS: One hundred and one VDU users, aged between 20 to 34y, initially participated in the study. This study excluded contact-lens wearers and subjects who had undergone refractive surgery or had any systemic or ocular disease. First, subjects were asked about the type and nature of eye symptoms they experienced during VDU use. Then, a thorough eye examination excluded those subjects with a significant uncorrected refractive error or other problem, such as ocular motility disorders, vertica…

0301 basic medicinenon-strabismic binocular dysfunctionsUlls Acomodació i refraccióRefractive errormedicine.medical_specialtyConvergence insufficiencygenetic structuresAccommodative insufficiencymedicine.medical_treatmentaccommodative dysfunctionsPopulationAudiologyOptometria03 medical and health sciences0302 clinical medicinelcsh:OphthalmologyRefractive surgerygeneral binocular dysfunctionsmedicineeducationInvestigationeye symptomseducation.field_of_studymedicine.diagnostic_testbusiness.industryFusional vergencemedicine.diseaseeye diseasesOphthalmology030104 developmental biologyEye examinationlcsh:RE1-994030220 oncology & carcinogenesis505video display unitbusinessBinocular vision
researchProduct

Role of Ocular Angiogenic Factors in the Development of Neovascular Age-Related Macular Degeneration

2020

Abstract Age-related macular degeneration (AMD) is a progressive degenerative eye disease. Neovascular age-related macular degeneration (nAMD) is the advanced form of AMD characterised by abnormal growth of newly formed blood vessels in chorioidea which typically involves fluid accumulation in the retina or retinal haemorrhage, retinal epithelial detachments, hard exudate or subretinal scars. The process of angiogenesis is controlled by ocular angiogenic factors, which have enabled the development of different treatment options aimed at these factors. This review aims to compile the available information about the most commonly identified ocular angiogenic factors, uncovering their role in …

0301 basic medicinepigment epithelium-derived factormedicine.medical_specialtyMultidisciplinaryvascular endothelial growth factorgenetic structuresGeneral interestScienceangiogenic factorsQbiomarkersMacular degenerationmedicine.diseaseeye diseases03 medical and health sciences030104 developmental biology0302 clinical medicineAge relatedOphthalmology030221 ophthalmology & optometrymedicinesense organsProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
researchProduct

Analysis of Lipid Peroxidation by UPLC-MS/MS and Retinoprotective Effects of the Natural Polyphenol Pterostilbene

2021

The loss of redox homeostasis induced by hyperglycemia is an early sign and key factor in the development of diabetic retinopathy. Due to the high level of long-chain polyunsaturated fatty acids, diabetic retina is highly susceptible to lipid peroxidation, source of pathophysiological alterations in diabetic retinopathy. Previous studies have shown that pterostilbene, a natural antioxidant polyphenol, is an effective therapy against diabetic retinopathy development, although its protective effects on lipid peroxidation are not well known. Plasma, urine and retinas from diabetic rabbits, control and diabetic rabbits treated daily with pterostilbene were analyzed. Lipid peroxidation was evalu…

0301 basic medicinepterostilbeneAntioxidantPterostilbenePhysiologymedicine.medical_treatmentClinical BiochemistryPharmacologymedicine.disease_causeBiochemistryArticleLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDiabetes mellitusmedicineoxidative stress[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansMolecular Biologypolyphenolschemistry.chemical_classificationlcsh:RM1-950lipid peroxidationCell BiologyDiabetic retinopathy[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismmedicine.disease3. Good healthdiabetic retinopathy030104 developmental biologylcsh:Therapeutics. PharmacologychemistryDocosahexaenoic acid030221 ophthalmology & optometry[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologybiomarkerOxidative stressPolyunsaturated fatty acidAntioxidants
researchProduct

Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials

2020

Current therapies for diabetic retinopathy (DR) incorporate blood glucose and blood pressure control, vitrectomy, photocoagulation, and intravitreal injections of anti-vascular endothelial growth factors or corticosteroids. Nonetheless, these techniques have not been demonstrated to completely stop the evolution of this disorder. The pathophysiology of DR is not fully known, but there is more and more evidence indicating that oxidative stress is an important mechanism in the progression of DR. In this sense, antioxidants have been suggested as a possible therapy to reduce the complications of DR. In this review we aim to assemble updated information in relation to in vitro experiments, anim…

0301 basic medicineretinaantioxidantPhysiologyEstrès oxidatiumedicine.medical_treatmentClinical BiochemistryVitrectomyReviewmedicine.disease_causeBioinformaticsBiochemistryAntioxidants03 medical and health sciences0302 clinical medicineDiabetic retinopathymedicineoxidative stressanimalhumanMolecular Biologybusiness.industryMechanism (biology)lcsh:RM1-950in vitroclinical trialCell BiologyDiabetic retinopathycellmedicine.diseasePathophysiologyIn vitroClinical trialdiabetic retinopathy030104 developmental biologylcsh:Therapeutics. PharmacologyOxidative stressRetinopatia diabètica030221 ophthalmology & optometryAnimal studiespatientbusinessOxidative stress
researchProduct